Evado launches into Asia

By Staff Writers
Wednesday, 22 October, 2008

Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.

Evado is being distributed by local clinical research company SeerPharma.

Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.

It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.

Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.

Related News

Shorter radiotherapy course proves safe for prostate cancer

A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...

5-in-1 meningococcal vaccine proves effective

A life-saving meningococcal vaccine covering all five common strains of the deadly disease could...

Diabetes drug reduces knee arthritis pain in overweight patients

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd